Yüklüyor......
Ursodeoxycholic acid attenuates the expression of proinflammatory cytokines in periodontal cells
BACKGROUND: Ursodeoxycholic acid (UDCA) is one of the first‐line therapeutic medications used in treatment of cholestatic liver disease. Considering that periodontitis is epidemiologically linked to liver diseases, the question arises weather UDCA holds anti‐inflammatory properties on periodontal he...
Kaydedildi:
| Yayımlandı: | J Periodontol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7496100/ https://ncbi.nlm.nih.gov/pubmed/31960968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/JPER.19-0013 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|